Skip to main content
. 2017 Jul 25;143(11):2327–2339. doi: 10.1007/s00432-017-2480-9

Table 4.

The number of patients according to frequency of TACE sessions after each first treatment modality in patients with RPRTs (n = 1357)

Initial treatment TACE session frequency
None 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Median no. (range)
Resection (n = 202) 73 37 25 26 11 14 3 4 2 3 1 1 1 0 1 0 0 0 0 0 3 (1–14)
RFA/PEI (n = 31) 10 10 3 3 2 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 2 (1–9)
TACE (n = 977) 283 181 136 101 69 53 50 27 24 16 14 9 6 3 4 0 0 0 0 1 3 (1–19)
EBRT (n = 65) 36 12 5 6 2 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 2 (1–8)
Chemotherapy (n = 72) 58 6 3 2 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 2 (1–10)
Total (n = 1357) 464 250 173 138 85 70 55 31 29 20 16 10 7 3 5 0 0 0 0 1 3 (1–19)

RPRTs recurring, progressing, or remaining tumors, RFA radiation frequency ablation, PEI percutaneous ethanol injection, TACE transarterial chemoembolization, EBRT external beam radiation therapy